Shares in Zimmer Biomet (NYSE:ZBH) rose today after the medical device maker beat expectations on Wall Street with its fourth quarter and full year 2018 earnings results. The Warsaw, Ind.-based company posted losses of $902.5 million, or $4.42 per share, on sales of approximately $2.07 billion for the three months ended December 31, seeing a swing […]
Zimmer Biomet wins FDA nod for Rosa Knee robotic surgical system
Zimmer Biomet (NYSE:ZBH) said today that it won FDA 510(k) clearance for its Rosa Knee robotically-assisted total knee replacement surgery platform. The newly cleared Rosa Knee system includes 3D pre-operative planning tools and real-time intraoperative data on soft tissue and bone anatomy to improve bone cut accuracy and range of motion gap analysis, the Warsaw, Ind.-based […]
Analyst downgrades pressure medtech stocks
Several medical device companies took hits yesterday after analysts on Wall Street downgraded their stocks, on a day when the major market indices each closed up a hair, and even medtech firms that enjoyed upgrades came under pressure. Globus Medical (NYSE:GMED) suffered the most after Morgan Stanley analyst David Lewis cut his rating on the stock from […]
Sanuwave confirms acting CEO Richardson as company head | Personnel Moves – December 12, 2018
Sanuwave said late last month that it lifted acting CEO and board chair Kevin Richardson to a permanent position in the corner office. Richardson joined the Suwanee, Ga.-based company in 2009 as board chair, and has served as acting CEO since 2014. He also served as managing partner of investment management firm Prides Capital from […]
Appeals court OKs $248m Stryker win over Zimmer Biomet
The U.S. Court of Appeals for the Federal Circuit this week affirmed Stryker‘s (NYSE:SYK) enhanced $248 million win in a surgical tool patent case against Zimmer Biomet (NYSE:ZBH). The Federal Circuit court affirmed the judgement in a per curiam ruling dated on Monday, according to recently released court documents. The damages in the case were previously […]
Ex-Zimmer Biomet SVP loses in court
A former Zimmer Biomet executive has temporarily lost her bid for severance pay and cannot claim company stock options after her 2016 resignation. Robin Barney resigned from her post as a senior vice president claiming a hostile work environment, alleging sex discrimination, breach of contract, and constructive or involuntary discharge. Barney became Zimmer’s SVP of […]
Medtech companies, industry groups shrug off ICIJ’s “Implant Files” report
Medtech companies and industry groups have shrugged off the highly critical, recently released “Implant Files” report from the International Consortium of Investigative Journalists, seeing major medtech company shares stay steady or rise in the wake of its posting. The highly critical “Implant Files” report, which was released early this week, is a collaborative effort overseen […]
Zimmer Biomet recalls bone stimulators on contamination risk
Zimmer Biomet (NYSE:ZBH) recalled nearly 1,400 bone stimulators on the risk that they could be contaminated with bacteria or chemicals, the FDA said yesterday. The Class I recall, denoting the risk of serious injury or death, covers 1,360 implantable bone growth and spinal fusion stimulators made and distributed between February 2015 and March 2018, including Zimmer […]
Is the medical device industry endangering people?
The highly critical “Implant Files” report overseen by the International Consortium of Investigative Journalists skewers the medtech industry as a whole and singles out particular companies and regulatory agencies for more intense scrutiny. The Implant Files is the second large-scale swipe at the medtech industry this year, following Netflix’s documentary, The Bleeding Edge. It includes six stories about […]
FDA clears Zimmer Biomet’s Persona knee implant
Zimmer Biomet (NYSE:ZBH) said today that the FDA granted 510(k) clearance for its Persona revision knee implant. Warsaw, Ind.-based Zimmer said the Persona system is designed to match each patient’s unique anatomy with customized components. “The clearance of the Persona revision knee system gives us the ability to provide surgeons with a full service portfolio for […]
Zimmer Biomet posts another sales & earnings beat
Zimmer Biomet (NYSE:ZBH) today posted third-quarter results that topped expectations for both sales and earnings and stood by its prior forecast for the rest of the year. The Warsaw, Ind.-based orthopedics giant reported profits of $162.2 million, or 79¢ per share, on sales of $1.84 billion for the three months ended Sept. 30, for a bottom-line […]
- 1
- 2
- 3
- …
- 35
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube